Search - tctmd.com

Displaying 81 - 100 of 750

Sort: Relevancy | Date

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

Talking Sex: CVD Patients Want to Hear More From Clinicians

News Conference News AHA 2024

Talking Sex: CVD Patients Want to Hear More From Clinicians

November 20, 2024

No Big Jumps in Smartwatch Accuracy for AF Detection Over Time

News Daily News

No Big Jumps in Smartwatch Accuracy for AF Detection Over Time

November 20, 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

News Daily News

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Yael L. Maxwell

November 14, 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

November 14, 2024

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

November 13, 2024

Private Equity Firms Own Half of Cardiology Practices: MedAxiom Survey

News Daily News

Private Equity Firms Own Half of Cardiology Practices: MedAxiom Survey

November 12, 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

October 28, 2024

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

News Conference News TCT 2024

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

October 27, 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Shared Decision-Making: A Toolkit for the Heart Team

Presentation TCT 2024

Shared Decision-Making: A Toolkit for the Heart Team

Presenter: Megan Coylewright

October 27, 2024

TCT 208: Meta-Heart Team: Enhancing Multidisciplinary Heart Teams Through Virtual Reality in the Metaverse

Presentation TCT 2024

TCT 208: Meta-Heart Team: Enhancing Multidisciplinary Heart Teams Through Virtual Reality in the Metaverse

Presenter: Ioannis Skalidis

October 27, 2024

October 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

October 25, 2024

Heart Failure and Cancer: HFSA Statement Explores the Interplay

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

October 24, 2024

The Cardiovascular Consequences of War

News Daily News

The Cardiovascular Consequences of War

October 23, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.